Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Profiling critical cancer gene mutations in clinical tumor samples.

MacConaill LE, Campbell CD, Kehoe SM, Bass AJ, Hatton C, Niu L, Davis M, Yao K, Hanna M, Mondal C, Luongo L, Emery CM, Baker AC, Philips J, Goff DJ, Fiorentino M, Rubin MA, Polyak K, Chan J, Wang Y, Fletcher JA, Santagata S, Corso G, Roviello F, Shivdasani R, Kieran MW, Ligon KL, Stiles CD, Hahn WC, Meyerson ML, Garraway LA.

PLoS One. 2009 Nov 18;4(11):e7887. doi: 10.1371/journal.pone.0007887. Erratum in: PLoS One. 2010;5(9). doi: 10.1371/annotation/613c7509-e4c9-42ac-82fb-fc504400d9e0. PLoS One. 2010;5(9). doi: 10.1371/annotation/3a0c8fee-57ef-43ed-b6c2-55b503e6db5e.

2.

High-throughput detection of clinically relevant mutations in archived tumor samples by multiplexed PCR and next-generation sequencing.

Bourgon R, Lu S, Yan Y, Lackner MR, Wang W, Weigman V, Wang D, Guan Y, Ryner L, Koeppen H, Patel R, Hampton GM, Amler LC, Wang Y.

Clin Cancer Res. 2014 Apr 15;20(8):2080-91. doi: 10.1158/1078-0432.CCR-13-3114. Epub 2014 Feb 26.

3.

High throughput interrogation of somatic mutations in high grade serous cancer of the ovary.

Matulonis UA, Hirsch M, Palescandolo E, Kim E, Liu J, van Hummelen P, MacConaill L, Drapkin R, Hahn WC.

PLoS One. 2011;6(9):e24433. doi: 10.1371/journal.pone.0024433. Epub 2011 Sep 8.

4.

Next generation MUT-MAP, a high-sensitivity high-throughput microfluidics chip-based mutation analysis panel.

Schleifman EB, Tam R, Patel R, Tsan A, Sumiyoshi T, Fu L, Desai R, Schoenbrunner N, Myers TW, Bauer K, Smith E, Raja R.

PLoS One. 2014 Mar 21;9(3):e90761. doi: 10.1371/journal.pone.0090761. eCollection 2014. Erratum in: PLoS One. 2014;9(4):e96019.

5.

Machine learning from concept to clinic: reliable detection of BRAF V600E DNA mutations in thyroid nodules using high-dimensional RNA expression data.

Diggans J, Kim SY, Hu Z, Pankratz D, Wong M, Reynolds J, Tom E, Pagan M, Monroe R, Rosai J, Livolsi VA, Lanman RB, Kloos RT, Walsh PS, Kennedy GC.

Pac Symp Biocomput. 2015:371-82.

6.

A multiplex technology platform for the rapid analysis of clinically actionable genetic alterations and validation for BRAF p.V600E detection in 1549 cytologic and histologic specimens.

Smith DL, Lamy A, Beaudenon-Huibregtse S, Sesboüé R, Laosinchai-Wolf W, Sabourin JC, Labourier E.

Arch Pathol Lab Med. 2014 Mar;138(3):371-8. doi: 10.5858/arpa.2013-0002-OA. Epub 2013 Jun 28.

PMID:
23808402
7.

Rapid targeted somatic mutation analysis of solid tumors in routine clinical diagnostics.

Magliacane G, Grassini G, Bartocci P, Francaviglia I, Dal Cin E, Barbieri G, Arrigoni G, Pecciarini L, Doglioni C, Cangi MG.

Oncotarget. 2015 Oct 13;6(31):30592-603. doi: 10.18632/oncotarget.5190.

8.

Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens.

Pritchard CC, Salipante SJ, Koehler K, Smith C, Scroggins S, Wood B, Wu D, Lee MK, Dintzis S, Adey A, Liu Y, Eaton KD, Martins R, Stricker K, Margolin KA, Hoffman N, Churpek JE, Tait JF, King MC, Walsh T.

J Mol Diagn. 2014 Jan;16(1):56-67. doi: 10.1016/j.jmoldx.2013.08.004. Epub 2013 Nov 2.

9.

Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.

Tabone T, Abuhusain HJ, Nowak AK; Australian Genomics and Clinical Outcome of Glioma (AGOG) Network, Erber WN, McDonald KL.

J Clin Pathol. 2014 Jul;67(7):550-5. doi: 10.1136/jclinpath-2014-202173. Epub 2014 Apr 2.

PMID:
24695838
10.

Mutations in the WTX-gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers.

Scheel SK, Porzner M, Pfeiffer S, Ormanns S, Kirchner T, Jung A.

BMC Cancer. 2010 Aug 9;10:413. doi: 10.1186/1471-2407-10-413.

11.
12.

Prospective, high-throughput molecular profiling of human gliomas.

Chi AS, Batchelor TT, Dias-Santagata D, Borger D, Stiles CD, Wang DL, Curry WT, Wen PY, Ligon KL, Ellisen L, Louis DN, Iafrate AJ.

J Neurooncol. 2012 Oct;110(1):89-98. doi: 10.1007/s11060-012-0938-9. Epub 2012 Jul 22.

13.

Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status.

Pappa KI, Choleza M, Markaki S, Giannikaki E, Kyroudi A, Vlachos G, Voulgaris Z, Anagnou NP.

Gynecol Oncol. 2006 Mar;100(3):596-600. Epub 2005 Oct 26.

PMID:
16256179
14.

Mutation analysis of the BRAF codon 599 in malignant pleural mesothelioma by enriched PCR-RFLP.

Dote H, Tsukuda K, Toyooka S, Yano M, Pass HI, Shimizu N.

Oncol Rep. 2004 Feb;11(2):361-3.

PMID:
14719068
15.

Detection of BRAF V600E mutation by pyrosequencing.

Tan YH, Liu Y, Eu KW, Ang PW, Li WQ, Salto-Tellez M, Iacopetta B, Soong R.

Pathology. 2008 Apr;40(3):295-8. doi: 10.1080/00313020801911512.

PMID:
18428050
16.

Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.

Sadi AM, Wang DY, Youngson BJ, Miller N, Boerner S, Done SJ, Leong WL.

BMC Cancer. 2011 Jun 16;11:253:1-13. doi: 10.1186/1471-2407-11-25.

17.

High-throughput oncogene mutation profiling in human cancer.

Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, Wang M, Feng W, Zander T, MacConaill L, Lee JC, Nicoletti R, Hatton C, Goyette M, Girard L, Majmudar K, Ziaugra L, Wong KK, Gabriel S, Beroukhim R, Peyton M, Barretina J, Dutt A, Emery C, Greulich H, Shah K, Sasaki H, Gazdar A, Minna J, Armstrong SA, Mellinghoff IK, Hodi FS, Dranoff G, Mischel PS, Cloughesy TF, Nelson SF, Liau LM, Mertz K, Rubin MA, Moch H, Loda M, Catalona W, Fletcher J, Signoretti S, Kaye F, Anderson KC, Demetri GD, Dummer R, Wagner S, Herlyn M, Sellers WR, Meyerson M, Garraway LA.

Nat Genet. 2007 Mar;39(3):347-51. Epub 2007 Feb 11. Erratum in: Nat Genet. 2007 Apr;39(4):567. Macconnaill, Laura E [corrected to MacConaill, Laura].

PMID:
17293865
18.

Predictive biomarkers in adult gliomas: the present and the future.

Thomas L, Di Stefano AL, Ducray F.

Curr Opin Oncol. 2013 Nov;25(6):689-94. doi: 10.1097/CCO.0000000000000002. Review.

PMID:
24076583
19.

A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.

Sarkar FH, Valdivieso M, Borders J, Yao KL, Raval MM, Madan SK, Sreepathi P, Shimoyama R, Steiger Z, Visscher DW, et al.

Diagn Mol Pathol. 1995 Dec;4(4):266-73.

PMID:
8634783
20.

Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors.

Pichler M, Balic M, Stadelmeyer E, Ausch C, Wild M, Guelly C, Bauernhofer T, Samonigg H, Hoefler G, Dandachi N.

J Mol Diagn. 2009 Mar;11(2):140-7. doi: 10.2353/jmoldx.2009.080100. Epub 2009 Feb 12.

Supplemental Content

Support Center